Page last updated: 2024-09-05

etravirine and Mood Disorders

etravirine has been researched along with Mood Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campbell, TB; Girard, PM; Grinsztejn, B; Hartikainen, J; Nijs, S; Rachline, A; Witek, J1
Berger, DS; Blick, G; Cimoch, PJ; Cohen, CJ; Greenberg, RN; Hicks, CB; Hoetelmans, RM; Iveson, KJ; Jayaweera, DS; Mills, AM; Nadler, JP; Peeters, MP; Ruane, PJ; Schrader, SR; Shalit, P; Smith, SM; Steinhart, CR; Thompson, M; Vingerhoets, JH; Voorspoels, E; Ward, D; Woodfall, B1

Trials

2 trial(s) available for etravirine and Mood Disorders

ArticleYear
Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest.
    HIV medicine, 2012, Volume: 13, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Dizziness; Double-Blind Method; Exanthema; Female; Headache; Humans; Male; Middle Aged; Mood Disorders; Nitriles; Pyridazines; Pyrimidines; Sleep Wake Disorders; Viral Load

2012
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis.
    AIDS (London, England), 2007, Mar-30, Volume: 21, Issue:6

    Topics: Adult; CD4 Lymphocyte Count; Dreams; Drug Administration Schedule; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Mood Disorders; Mutation; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load

2007